Aspirin is the antithrombotic drug of choice for acute infarction of the right centrum semiovale
For an acute ischemic stroke of the right centrum semiovale, initiate aspirin 160-325 mg within 48 hours of symptom onset (Grade 1A). This represents the highest level of evidence-based recommendation for antithrombotic therapy in acute ischemic stroke 1.
Acute Phase Management Algorithm
Within the Thrombolysis Window (< 4.5 hours)
- If presenting within 3 hours: IV recombinant tissue plasminogen activator (r-tPA) is the priority treatment (Grade 1A) 1
- If presenting between 3-4.5 hours: IV r-tPA is suggested (Grade 2C) 1
- After thrombolysis or if ineligible: Start aspirin 160-325 mg once thrombolysis is excluded or completed
Beyond the Thrombolysis Window (> 4.5 hours)
- Initiate aspirin 160-325 mg immediately within 48 hours of symptom onset 1
- This provides modest but statistically significant benefit primarily through prevention of early recurrent stroke
- Aspirin is superior to therapeutic anticoagulation in the acute phase (Grade 1A) 1
Key Evidence Supporting Aspirin
The recommendation is based on two large trials (IST and CAST) that demonstrated:
- Reduction in early stroke recurrence
- Modest improvement in functional outcomes at 3 months
- Acceptable safety profile with only minor increase in bleeding complications
- Primary benefit from preventing recurrent ischemic events rather than limiting acute neurological damage 2
Important Caveats
Anticoagulation is NOT recommended for routine acute ischemic stroke management:
- Full-dose heparin or low-molecular-weight heparin should NOT be used therapeutically (Grade 1A) 1
- Anticoagulation only considered in specific high-risk scenarios (not applicable to typical centrum semiovale infarction):
- Cerebral venous thrombosis
- Arterial dissection
- High-risk cardioembolic source with imminent recurrence risk
VTE prophylaxis is separate: If the patient has restricted mobility, add prophylactic-dose subcutaneous LMWH or intermittent pneumatic compression devices (Grade 2B) 1
Timing Considerations
- Start aspirin within 48 hours of symptom onset
- Do not delay beyond this window
- If thrombolysis was administered, wait 24 hours before starting aspirin to minimize hemorrhagic risk
The centrum semiovale location (subcortical white matter) represents a typical noncardioembolic ischemic stroke territory, making aspirin the clear first-line antithrombotic choice unless specific contraindications exist or a cardioembolic source (like atrial fibrillation) is identified—in which case anticoagulation would be considered for secondary prevention after the acute phase.